UK orders 100mn doses of French Valneva COVID-19 vaccine candidate
Topics: FRENCH VALNEVA UK
The jab is still undergoing early clinical trials.
The massive order was announced by the drugmaker and the British government on Monday. Britain is also eligible to order a further 90 million doses between 2023 and 2025, which would bring the deal’s worth to up to €1.4 billion ($1.7 billion).
“The further 40 million doses secured through today’s deal significantly bolsters our portfolio and gives us future flexibility should we need to revaccinate any of the UK population,” said Clive Dix, interim chair of the UK government’s Vaccines Taskforce.
While the vaccine is still in the early clinical trial stage, the company has already begun commercial manufacturing at a plant in Scotland, Valneva’s CEO Thomas Lingelbach said in a statement. ■